TAAR1 and Insulin resistance: We demonstrated tryptamine and phenethylamine actions on ERK activation and inhibition of insulin signaling pathway can be abolished by TAAR1 antagonist and genetic ablation of Taar1, representing targeting TAAR1-MAPK/ERK signaling axis as a potential therapeutic strategy to combat R. gnavus-induced insulin resistance.